ORKAOruka Therapeutics, Inc.

$99.48

What is the market doing?

What the tape says about ORKA

Oruka Therapeutics, Inc. is +628% over the past year while the S&P 500 is +23%: 605 points ahead of the market.

+628%

1-year return · S&P 500 +23%

vs 200-day average
+91%

vs 200-day average · a clear uptrend

RSI (14)
52

RSI (14) · neutral

Below its 52-week high
−12%

Below its 52-week high

2024-08-06$6.78 – $113.05 · dashed line: 200-day average2026-08-26
Details
Last close2026-08-26
$99.48
1 monthS&P 500 +3.7%
+8.2%
1 yearS&P 500 +23%
+628%
5 yearsS&P 500 +87%
+383%
vs 50-day average$86.80
+15%
52-week high
$113.05
52-week low
$13.05
Annualised volatility
83%
Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
−$356K
Calendar-year price return
YearReturn
2026 (year to date)+228%
2025+56%
2024+77%
2023−28%
2022+10%
2021−46%
2020−30%
2019−3.9%
2018−76%
2017−53%
Average return by calendar month, 2016–2026
MonthYearsPositiveAverage
Jan104 of 10−0.45%
Feb105 of 10−8.4%
Mar104 of 10−4.4%
Apr108 of 10+15%
May108 of 10+26%
Jun105 of 10+3.3%
Jul116 of 11+2.2%
Aug114 of 11−4.7%
Sep102 of 10−3.3%
Oct105 of 10+3.1%
Nov106 of 10−1.6%
Dec105 of 10−2.7%

End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.